Document Detail


EphrinA1 is released in three forms from cancer cells by matrix metalloproteases.
MedLine Citation:
PMID:  22688511     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
EphrinA1 is a glycosylphosphatidylinositol (GPI)-linked ligand for the EphA2 receptor, which is overexpressed in glioblastoma (GBM), among other cancers. Activation of the receptor by ephrinA1 leads to a suppression of oncogenic properties of GBM cells. We documented that a monomeric functional form of ephrinA1 is released from cancer cells and thus explored the mechanism of ephrinA1 release and the primary protein sequence. We demonstrate here that multiple metalloproteases (MMPs) are able to cleave ephrinA1, most notably MMP-1, -2, -9, and -13. The proteolytic cleavage that releases ephrinA1 occurs at three positions near the C terminus, producing three forms ending in valine-175, histidine-177, or serine-178. Moreover, deletion of amino acids 174 to 181 or 175 to 181 yields ephrinA1 that is still GPI linked but not released by proteolysis, underlining the necessity of amino acids 175 to 181 for release from the membrane. Furthermore, recombinant ephrinA1 ending at residue 175 retains activity toward the EphA2 receptor. These findings suggest a mechanism of release and provide evidence for the existence of several forms of monomeric ephrinA1. Moreover, ephrinA1 should be truncated at a minimum at amino acid 175 in fusions or conjugates with other molecules in order to prevent likely proteolysis within physiological and pathobiological environments.
Authors:
Amanda Beauchamp; Mark O Lively; Akiva Mintz; Denise Gibo; Jill Wykosky; Waldemar Debinski
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-06-11
Journal Detail:
Title:  Molecular and cellular biology     Volume:  32     ISSN:  1098-5549     ISO Abbreviation:  Mol. Cell. Biol.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-30     Completed Date:  2012-10-16     Revised Date:  2013-07-12    
Medline Journal Info:
Nlm Unique ID:  8109087     Medline TA:  Mol Cell Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3253-64     Citation Subset:  IM    
Affiliation:
Department of Neurosurgery, Brain Tumor Center of Excellence, Comprehensive Cancer Center of Wake Forest University, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Cell Line, Tumor
Cell Movement
Culture Media, Conditioned / pharmacology
Ephrin-A1 / metabolism,  physiology*
Gene Expression Regulation, Enzymologic*
Gene Expression Regulation, Neoplastic*
Humans
Ligands
Mass Spectrometry / methods
Matrix Metalloproteinases / metabolism*
Molecular Sequence Data
Mutation
Neoplasms / metabolism*
Peptides / chemistry
Phosphoinositide Phospholipase C / pharmacology
Proteolysis
Recombinant Proteins / metabolism
Transfection
Grant Support
ID/Acronym/Agency:
CA139099/CA/NCI NIH HHS; R01 CA74145/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Culture Media, Conditioned; 0/Ephrin-A1; 0/Ligands; 0/Peptides; 0/Recombinant Proteins; EC 3.1.4.11/Phosphoinositide Phospholipase C; EC 3.4.24.-/Matrix Metalloproteinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Drosophila lin-52 acts in opposition to repressive components of the Myb-MuvB/dREAM complex.
Next Document:  Regulation of cell migration by sphingomyelin synthases: sphingomyelin in lipid rafts decreases resp...